A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives
So much of the fairy tale called "progress" involves Technology leading Demand to a clearing in the woods, where appears the magic maguffin. "This is what you want," Technology says.
But is it? Who recalls pining through the '80s because high-definition television hadn't been invented yet? Was there ever a huge outcry against turning lights on manually?
Then, there are the breakthroughs brought to us by Demand: air bags because we needed safer cars, smoke detectors because we needed safer homes, and antiretroviral therapies because we needed safer futures.
"I'll take these," says Demand.
The Health Care Financing Administration is throwing its resources behind demand, and hoping technology catches up. HCFA plans to use a new risk-adjusted methodology in Medicare+Choice beginning Jan. 1, 2000. In this way, the agency wants to meet the demand for a level playing field in which high-quality plans and providers are not, in essence, penalized for providing exemplary care. (This launch is being readied even as many HMOs are bailing out and the future of managed Medicare becomes more problematic.) Medicare risk adjustment will use inpatient hospital utilization in one year to predict the cost of all services in the following year.
"That's quite a jump," points out David C. Harlow, a health care partner in the Boston law firm of Posternak, Blankstein & Lund. "HCFA plans to gather more and more encounter data so that it will not have to rely on projections." The agency will use what data it can until health care information systems and data-collection efforts advance to the point where they can produce all of the data the agency needs for its risk-adjusting efforts. Meanwhile, the private sector will be watching because today's government program could be tomorrow's popular movement.
Lisa Iezzoni, M.D., a professor of medicine at Harvard Medical School and author of Risk Adjustment for Measuring Health Care Outcomes, says the feasibility of using the system turns on two issues.
"The first is data collection," says Iezzoni. "You can't do risk adjustment without data. Under the Medicare program, HCFA has the authority to tell managed care plans to submit the data. However, this could require costly changes in plans' information systems, and some plans could leave Medicare because of this." There would be no such directive bolstering any risk-adjusted methodology attempted in the private sector. "Non-Medicare participating plans," says Iezzoni, "would have to voluntarily produce the data. You really can't separate the issue of risk adjustment from information-gathering capabilities."
The second issue, according to Iezzoni, involves the difficulty of predicting health care costs, even with hard-to-get clinical data. "We do have methods that do better than the age-and-sex method, but in no way are these other methods perfect," says Iezzoni. "One problem with trying to predict future costs is that they're so random — 25 percent of it may be predictable. The other 75 percent is going to be random or acts of God or however you want to put it. There are a lot of people who are going to have no costs this year but will come down with a serious, resource-draining disease next year. There's often no way to predict that."
The randomness of health care could wind up being a particularly costly hurdle for practices with few capitated patients. "Provider groups are going to be concerned about small numbers," says Iezzoni. "They're going to be concerned that one or two very ill patients are going to break the bank, so to speak. Policies are needed to stop losses."
Despite these hurdles, Iezzoni and many others say an attempt must be made to implement risk adjustment.
"I think it's the single most important and most difficult technological issue facing health care," says Gail R. Wilensky, Ph.D., who chairs the Medicare Payment Advisory Commission, a body that reports to Congress on Medicare expenditure issues. "This is a trail that Medicare will pave and others will follow." (See "How Risk Adjustment Will Work in Medicare")
Some of those who will follow may have to be dragged along.
A representative of one major HMO, who spoke on condition that his name be withheld, says that the fact that the federal government is behind the biggest risk-adjusted program ever attempted makes commenting on the methodology a sticky situation. "For us to assess it one way or another could be dicey," the spokesman adds.
Says Donald White, a spokesman for the American Association of Health Plans: "We're trying to understand it as best we can at this point. The question is, 'How will risk adjustment be constructed?'"
Indeed, that's one of the questions contained in a 10-page letter sent by Candace Schaller, the association's vice president for regulatory affairs, to Nancy-Ann DeParle, HCFA's administrator. Can the right data be collected? Will health plans be able to switch to the new system by 2000? Will the data lead plans and HCFA to the same conclusions?
White directs further questions to John Bertko, a principal with the San Francisco-based consultancy Reden & Anders who advises the organization on risk adjustment.
"The question to ask isn't if risk adjustment can work but, rather, where has it been working?" says Bertko.
The answer is that several large employer purchasing consortiums, including the Minneapolis-based Business Health Care Action Group, have used the system.
Other areas where Bertko says risk adjustment exists are:
Harlow cites MassHealth, the Medicaid program administered by the Massachusetts Division of Medical Assistance, which establishes 10 different risk-adjusted rates each year for each nursing facility in the state. The adjustment in this instance is based on the number of nursing care minutes each patient receives.
Health plans also use risk adjustment, says Harlow. "Some of the managed care organizations that have contracts with nursing facilities will say, 'We're going to contract with you and, depending on the acuity level of the residents, we'll pay you Rate A, B or C.' This represents a movement away from a discounted fee-for-service calculation and a step toward establishment of standard rates for services. Payers using standard rates are indifferent to the costs incurred in providing services. This approach to payment is spreading and contributes to the urge to merge among providers, because economies of scale are the best provider response available to this sort of payer pressure."
Steven Eastaugh, Sc.D., professor of finance and health economics at George Washington University's School of Public Health and Health Services, ranges even further in looking for examples. "Name me a country that used to have diagnosis-related groups and that now has risk adjustment. The answer is Norway. It has one hundred twenty risk categories. Norway's system is based on ambulatory care and inpatient data. True, it's a lot easier to do it in a country with a fairly homogenous population of three million people, but it can be done."
In fact, Eastaugh contends that, in the interest of fairness, it must be done — or at least attempted.
"If you don't adjust for risk, you're probably discriminating against plans that enroll more than their fair share of the chronically ill," says Eastaugh. "I think it's definitely going to happen. There is an unstoppable force for fairness in the system."
Eric Meyers, M.B.A., vice president for marketing at HealthShare Technology, draws from his experience as a legislative assistant for former U.S. Rep. Stephen Solarz of New York in saying that risk adjustment — if the right technology is used — could replace DRGs. "DRGs don't do a good enough job beyond distinguishing between patients who are moderately ill and those who are severely ill," says Meyers. They don't recognize the difference, for instance, between an otherwise healthy 55-year-old man admitted to a hospital for pneumonia and a 55-year-old man, who isn't healthy, admitted for the same reason. "They're both listed as DRG 089 — 'adult pneumonia without complication,'" says Meyers. "But one might also have other problems. If that hospital happens to serve more people with comorbidities, the chances are pretty great that those patients are going to consume more resources. You obviously have to take that into account in compensating doctors for the care they provide."
Bertko agrees that, especially from the provider's viewpoint, fairness is the issue. "Risk adjustment offers a better way to allocate payments to providers who serve sicker people. In some cases, like academic medical centers, it makes a lot of sense because those centers are usually located in urban areas."
Despite the potential benefits, Bertko acknowledges that risk adjustment has not, relatively speaking, made substantial inroads. Of the approximately 100 million people in some form of managed care, only about 2 million are in risk-adjusted systems, he says.
That doesn't matter, says Bradford L. Kirkman-Liff, Dr. P.H., who is professor of health administration and policy at Arizona State University. "As a higher proportion of people go into managed care, the need for a good risk-adjusting methodology becomes more important," he says. "There is a great deal of variation in usage of health care services. Only a small fraction of patients accounts for a large proportion of care. So if people have a choice of plans, any plans that attract a few more sicker patients than other plans will have substantially higher costs."
But he isn't sure that using inpatient hospital data is the best way to proceed. "I think use of durable medical equipment might be a better predictor of cost," says Kirkman-Liff.
It might also matter who's collecting the data. Employers may be faced with confidentiality concerns. "You have to collect detailed information on employees and their family members," says Kirkman-Liff. "You have to ask the kinds of things that, historically, employers have not asked employees and that employees have been reluctant to divulge to employers. This information is much more personal than the year and make of the car you drive."
And even in cases where employers ask, who's to say that employees will be forthright? "Right now the whole topic of employee health screening is becoming a huge issue," says Kirkman-Liff.
Any system whose proponents claim will level the playing field is sure to be regarded with mistrust by those who now benefit from an unleveled field, says Harlow, the lawyer. "Nobody who's going to wind up getting less money is going to think this is a good thing. Unless the risk-adjustment methodology is extremely accurate, the managed care companies might think they'll lose out. They might have planned to pay primary care physicians $15 per member per month and now they may be looking at paying $150 per member, per month for sicker members. It's a dollars-and-cents issue."
Dean Farley, Ph.D., vice president of health policy and analysis at Bethesda, Md.-based HSS, which develops and sells health care-related software, says that refining the science of risk adjustment and spreading the system throughout the country has long been touted as a way to bring more coverage to more people.
"For example, suppose HIV patients disproportionately enroll in health plans that offer superior benefits for HIV," says Farley. "Perhaps these plans contract with doctors who do the best job of treating HIV patients. Well, without risk adjustment, premiums for these plans will go up — or benefits will have to be cut back — because the disproportionate number of HIV patients will increase claims payments."
When you control premiums for a variety of insurance options — as Medicare does — you can use risk adjustment to match premiums to expected claims experience, Farley says. Plans with higher-than-average expected claims will get higher premiums. Those with lower-than-average expected claims will get lower premiums. If you capitate primary care physicians, you can use this same type of risk adjustment within a health plan.
"The difficulty with existing risk-adjusted systems is that, because they're based on historical utilization, current methods can at best predict only about ten percent of the actual variation in resource use," says Farley.
While most experts admit that data-collection capabilities aren't up to snuff yet, a vocal faction wants risk adjustment implemented anyway.
Mary Wakefield, Ph.D., the director of the Center for Health Care Policy and Ethics at George Mason University, cites findings by the U.S. Agency for Health Care Policy and Research that indicate 1 in every 3 Americans suffers from a chronic health problem. Such conditions eat up $1 of every $6 spent on health care.
These numbers point to the necessity of risk adjustment, says Wakefield.
"The technology may be rudimentary compared to what it might look like 15 years from now, but frankly, I don't see any other system working," says Wakefield. "Risk adjustment is not going to be perfected before it can be implemented."
Wilensky, who is also the John M. Olin Senior Fellow at Project HOPE, an international health foundation, agrees that it's better to start the process. "There is appropriate concern about whether or not the data are available," says Wilensky. "The real question is, 'How do you make sure you don't cause damage in Medicare+Choice while you wait the two or three years to get full encounter data?' I think the answer is to phase in the system. I would guess that by 2003 or 2004, we'll start to see a heavier focus on encounter data." (HCFA intends to mandate more data collection sometime after Oct. 1, 1999, says Bertko, the San Francisco consultant for AAHP.)
Plans will want to see how the methodology fares, though adjusting risk for the elderly is not the same as adjusting it for younger people.
"In some ways, it will be easier in the under-65 population because the extremes are more extreme," says Wilensky. "In the 65-and-older group, there's less difference between heavy and average users."
This is a point not lost on Bertko. "One third of all seniors are admitted to a hospital each year," he says. Only about 6 percent of younger people go.
One prediction Farley feels confident in making is that plans, trade associations and professional groups will lobby Congress to make sure they come out on top in any risk-adjusted scheme.
Such tensions can be considered a sign of development, says Eastaugh. "Risk adjustment is a slow-growing infant. But it's better to try something with imperfect data as a first draft and then improve it over time."
A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives
Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report